Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;227(1):125-9.
doi: 10.1016/j.atherosclerosis.2012.12.026. Epub 2013 Jan 1.

Rapid regression of atherosclerosis with MTP inhibitor treatment

Affiliations

Rapid regression of atherosclerosis with MTP inhibitor treatment

Bernd Hewing et al. Atherosclerosis. 2013 Mar.

Abstract

Objective: Regression of atherosclerosis is a vital treatment goal of atherosclerotic vascular disease. Inhibitors of the microsomal triglyceride transfer protein (MTP) have been shown to reduce apolipoprotein B (apoB)-containing lipoproteins in animals and humans effectively. Therefore, the major aim of our study is to evaluate the effect of MTP inhibition on atherosclerotic plaque regression.

Methods: LDL-receptor-deficient (LDLr(-/-)) mice were fed a Western diet for 16 weeks and then harvested for baseline (n = 8), switched to chow diet (n = 8) or chow diet containing MTP inhibitor (BMS 212122; n = 8) for 2 weeks before harvesting.

Results: Treatment with MTP inhibitor led to rapid reduction in plasma lipid levels, which were accompanied by a significant decrease in lipid content and monocyte-derived (CD68+) cells in atherosclerotic plaques compared to baseline and chow diet control groups. MTP inhibitor-treated mice had increased collagen content, a marker associated with increased stability in human plaques. Furthermore, plaques of these mice showed a significant decrease in tissue factor and pro-inflammatory M1 macrophage marker monocyte chemoattractant protein-1 (MCP-I) and an increase in anti-inflammatory M2 macrophage markers arginase-I and mannose receptor 1 compared to mice in the baseline group.

Conclusion: Reversal of hyperlipidemia in atherosclerotic mice by inhibition of MTP leads to rapid and beneficial changes in the composition and inflammatory state of the plaque.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A) Total plasma cholesterol levels, B) plasma TC/HDL ratios, and C-E) aortic root plaque sizes and Oil Red O staining (ORO) of plaques from LDLr−/− mice before (Baseline) and after switch to either a chow diet (Chow) or a chow diet containing MTP inhibitor (MTPi) for 2 weeks (magnification: 10×). Values are mean ± SEM; * p<0.05, ** p<0.01, *** p<0.001; n=8 in each group.
Fig. 2
Fig. 2
Plaques of aortic root sections stained for A) collagen (Sirius Red), B) macrophages (CD68+), C) tissue factor (TF), D) monocyte chemoattractant protein-1 (MCP-I), E) arginase-I and F) mannose receptor 1 (MR) from LDLr−/− mice before (Baseline) and after switch to either a chow diet (Chow) or a chow diet containing MTP inhibitor (MTPi) for 2 weeks (magnification: 10×; arginase-I: 20×). Values are mean ± SEM; * p<0.05, ** p<0.01, *** p<0.001; n=7–8 mice in each group.
Fig. 2
Fig. 2
Plaques of aortic root sections stained for A) collagen (Sirius Red), B) macrophages (CD68+), C) tissue factor (TF), D) monocyte chemoattractant protein-1 (MCP-I), E) arginase-I and F) mannose receptor 1 (MR) from LDLr−/− mice before (Baseline) and after switch to either a chow diet (Chow) or a chow diet containing MTP inhibitor (MTPi) for 2 weeks (magnification: 10×; arginase-I: 20×). Values are mean ± SEM; * p<0.05, ** p<0.01, *** p<0.001; n=7–8 mice in each group.

References

    1. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel iii guidelines. Circulation. 2004;110:227–239. - PubMed
    1. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The asteroid trial. Jama. 2006;295:1556–1565. - PubMed
    1. Brautbar A, Ballantyne CM. Pharmacological strategies for lowering ldl cholesterol: Statins and beyond. Nat Rev Cardiol. 2011;8:253–265. - PubMed
    1. Feig JE, Parathath S, Rong JX, et al. Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation. 2011;123:989–998. - PMC - PubMed
    1. Lieu HD, Withycombe SK, Walker Q, et al. Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation. 2003;107:1315–1321. - PubMed

Publication types

MeSH terms

Substances